These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24013554)

  • 21. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
    Manley HJ; Cannella CA
    Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study.
    Gavin AT; Donnelly D; Donnelly C; Drummond FJ; Morgan E; Gormley GJ; Sharp L
    BMJ Open; 2016 Dec; 6(12):e012952. PubMed ID: 27993906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cost of diabetes mellitus in Spain].
    González P; Faure E; Del Castillo A;
    Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
    [No Abstract]   [Full Text] [Related]  

  • 24. Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus.
    Maetzel A; Ruof J; Covington M; Wolf A
    Pharmacoeconomics; 2003; 21(7):501-12. PubMed ID: 12696990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stroke presentation and hospital management: comparison of neighboring healthcare systems with differing health policies.
    Crawford VL; Dinsmore JG; Stout RW; Donnellan C; O'Neill D; McGee H
    Stroke; 2009 Jun; 40(6):2143-8. PubMed ID: 19372441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study.
    Croker R; Walker AJ; Bacon S; Curtis HJ; French L; Goldacre B
    BMJ Open; 2018 Feb; 8(2):e019643. PubMed ID: 29439078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costs, outcomes and challenges for diabetes care in Spain.
    Lopez-Bastida J; Boronat M; Moreno JO; Schurer W
    Global Health; 2013 May; 9():17. PubMed ID: 23635075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Payment methods for healthcare providers working in outpatient healthcare settings.
    Jia L; Meng Q; Scott A; Yuan B; Zhang L
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011865. PubMed ID: 33469932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
    Cutler TW; Palmieri J; Khalsa M; Stebbins M
    J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case study of the effects of office-based generic drug sampling on antibiotic drug costs and first-line antibiotic prescribing ratios.
    Conklin MH; Culley EJ; O'Donnell J
    J Manag Care Pharm; 2009; 15(1):55-61. PubMed ID: 19125550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 2 diabetes detection and management among insured adults.
    Dall TM; Yang W; Halder P; Franz J; Byrne E; Semilla AP; Chakrabarti R; Stuart B
    Popul Health Metr; 2016; 14():43. PubMed ID: 27895533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity.
    Taylor JR; Dietrich E; Powell JG
    Clin Ther; 2013 Jan; 35(1):A3-17. PubMed ID: 23328274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and incidence of type 1 diabetes in Ireland: a retrospective cross-sectional study using a national pharmacy claims data from 2016.
    Gajewska KA; Biesma R; Sreenan S; Bennett K
    BMJ Open; 2020 Apr; 10(4):e032916. PubMed ID: 32312725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data.
    Huang Y; Vemer P; Zhu J; Postma MJ; Chen W
    PLoS One; 2016; 11(8):e0159297. PubMed ID: 27570976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
    Oh SH; Ku H; Park KS
    BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.
    Heinze G; Hronsky M; Reichardt B; Baumgärtel C; Müllner M; Bucsics A; Winkelmayer WC
    Appl Health Econ Health Policy; 2015 Apr; 13(2):193-205. PubMed ID: 25536928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight-Plus weight management programme within a primary care randomized controlled trial.
    Xin Y; Davies A; McCombie L; Briggs A; Messow CM; Grieve E; Leslie WS; Taylor R; Lean MEJ
    Diabet Med; 2019 Aug; 36(8):1003-1012. PubMed ID: 31026353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of overweight and obesity on the island of Ireland: results from the North South Survey of Children's Height, Weight and Body Mass Index, 2002.
    Whelton H; Harrington J; Crowley E; Kelleher V; Cronin M; Perry IJ
    BMC Public Health; 2007 Jul; 7():187. PubMed ID: 17672893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.